Primary Image

Generic Background Image

Clinical Trial

A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI)

IRB Protocol Number STU00202886


Sneha Solanki


This research study evaluates if modified stem cells (SB623 cells) given intracranially (into the brain) improve clinical motor function in patients who have experienced a traumatic brain injury (TBI). Cells are administered through a surgical procedure at one of three different cell doses, or participants receive the placebo surgery. Improvements in disability and safety are also being studied. 

Who Can Participate



Adult patients with fixed motor deficits from TBI, at least 12 months post-TBI 

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

Save now, read later.

More Studies Like This

view all

Latest Updates

view all